{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:06:26Z","timestamp":1786118786310,"version":"build-2736575974"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1097\/jcp.0b13e318033bd5e","type":"journal-article","created":{"date-parts":[[2007,3,19]],"date-time":"2007-03-19T03:57:26Z","timestamp":1174276646000},"page":"171-176","source":"Crossref","is-referenced-by-count":86,"title":["Management of Acute Agitation in Patients With Bipolar Disorder"],"prefix":"10.1097","volume":"27","author":[{"given":"Dan L.","family":"Zimbroff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald N.","family":"Marcus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Manos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elyse","family":"Stock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D.","family":"McQuade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Auby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan A.","family":"Oren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210128","first-page":"3","article-title":"Treatment of agitation in bipolar disorder across the life cycle.","volume":"64","author":"Alderfer","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"R2-9-20210128","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/00131746-200301000-00004","article-title":"Treatment of behavioral emergencies: a summary of the expert consensus guidelines.","volume":"9","author":"Allen","year":"2003","journal-title":"J Psychiatr Pract"},{"key":"R5-9-20210128","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/emj.20.4.339","article-title":"Pharmacological managemen t of agitation in emergency settings.","volume":"20","author":"Yildiz","year":"2003","journal-title":"Emerg Med J"},{"key":"R6-9-20210128","first-page":"11","article-title":"Managing the agitated psychotic patient: a reappraisal of the evidence.","volume":"61","author":"Allen","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"R7-9-20210128","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s002130000658","article-title":"Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double-blind, randomized trial.","volume":"155","author":"Daniel","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"R8-9-20210128","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4088\/JCP.v62n0104","article-title":"Intramuscular ziprasidone, 2 mg versus 10 mg, in the short-term management of agitated psychotic patients.","volume":"62","author":"Lesem","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"R9-9-20210128","doi-asserted-by":"crossref","first-page":"933","DOI":"10.4088\/JCP.v61n1208","article-title":"M. Study Group. Intramuscular ziprasidone compared with intramuscular haloperidol in the treatment of acute psychosis.","volume":"61","author":"Brook","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"R10-9-20210128","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00004850-200401000-00002","article-title":"The tolerability of intramuscular ziprasidone and haloperidol treatment and the transition to oral therapy.","volume":"19","author":"Daniel","year":"2004","journal-title":"Int Clin Psychopharmacol"},{"key":"R11-9-20210128","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/00004714-200108000-00006","article-title":"A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania.","volume":"21","author":"Meehan","year":"2001","journal-title":"J Clin Psychopharmacol"},{"key":"R12-9-20210128","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00213-006-0541-x","article-title":"Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder: a double-blind, placebo-controlled comparison with IM haloperidol.","volume":"188","author":"Andrezina","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"R13-9-20210128","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4088\/JCP.v68n0115","article-title":"Efficacy and safety of intramuscular aripiprazole in patients with acute agitation: a randomized, double-blind placebo-controlled trial.","volume":"68","author":"Tran-Johnson","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"R14-9-20210128","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia.","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr Bull"},{"key":"R16-9-20210128","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S0893-133X(01)00365-7","article-title":"Comparison of rapidly acting intramuscular olanzapine, lorazepam, and placebo: a double-blind, randomized study in acutely agitated patients with dementia.","volume":"26","author":"Meehan","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"R17-9-20210128","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1080\/01688639408402649","article-title":"Factor structure of the Agitated Behavior Scale.","volume":"16","author":"Corrigan","year":"1994","journal-title":"J Clin Exp Neuropsychol"},{"key":"R18-9-20210128","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity.","volume":"133","author":"Young","year":"1978","journal-title":"Br J Psychiatry"},{"key":"R19-9-20210128","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.2165\/00003495-200565090-00003","article-title":"Pharmacological management of acute agitation.","volume":"65","author":"Battaglia","year":"2005","journal-title":"Drugs"},{"key":"R20-9-20210128","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0735-6757(97)90119-4","article-title":"Haloperidol, lorazepam, or both for psychotic agitation? A multicenter, prospective, double-blind, emergency department study.","volume":"15","author":"Battaglia","year":"1997","journal-title":"Am J Emerg Med"},{"key":"R21-9-20210128","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00004850-199705000-00009","article-title":"Efficacy of lorazepam and haloperidol for rapid tranquilization in a psychiatric emergency room setting.","volume":"12","author":"Foster","year":"1997","journal-title":"Int Clin Psychopharmacol"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/JCP.0b13e318033bd5e","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:35:23Z","timestamp":1786034123000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004714-200704000-00009"}},"subtitle":["Efficacy and Safety of Intramuscular Aripiprazole"],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b13e318033bd5e","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}